Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin

Cancer Treat Res. 2008:140:235-51. doi: 10.1007/978-0-387-73639-6_14.
No abstract available

MeSH terms

  • Anemia / drug therapy*
  • Anemia / etiology
  • Decision Making / ethics
  • Erythropoietin / economics*
  • Erythropoietin / therapeutic use
  • Health Care Rationing / ethics
  • Hematinics / economics*
  • Hematinics / therapeutic use
  • Humans
  • Insurance, Health, Reimbursement*
  • Neoplasms / complications*
  • Patient Selection / ethics*
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians' / economics*
  • Practice Patterns, Physicians' / ethics
  • Recombinant Proteins
  • United States

Substances

  • Hematinics
  • Recombinant Proteins
  • Erythropoietin